Quince Therapeutics(QNCX.US)

Last Updated 19:00:00 ET
longbridge loading

Quince Therapeutics | 10-K: FY2025 Revenue: USD 0

Earnings Watch·
US
QNCX
+0.93%
Earnings Watch·
US
QNCX
+0.93%

Quince Therapeutics Announces 1-for-10 Reverse Stock Split

Tip Ranks·
US
IBB
+2.27%
US
PBE
+1.60%
US
BBH
+0.96%
Tip Ranks·
US
IBB
+2.27%
US
PBE
+1.60%
US
BBH
+0.96%

12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga_article·
US
ARKG
+5.05%
US
IBBQ
+2.43%
US
PBE
+1.60%
benzinga_article·
US
ARKG
+5.05%
US
IBBQ
+2.43%
US
PBE
+1.60%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
IBB
+2.27%
US
ARKG
+5.05%
US
QNCX
+0.93%
benzinga_article·
US
IBB
+2.27%
US
ARKG
+5.05%
US
QNCX
+0.93%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
+0.96%
US
KPRX
+4.76%
US
CUPR
-1.38%
benzinga_article·
US
PFSA
+0.96%
US
KPRX
+4.76%
US
CUPR
-1.38%

Quince Therapeutics shares are trading higher after the company announced a settlement of its outstanding obligations under a loan from the European Investment Bank for a payment of $5.5 million.

benzinga_article·
US
BIB
+4.98%
US
SBIO
+3.75%
US
QNCX
+0.93%
benzinga_article·
US
BIB
+4.98%
US
SBIO
+3.75%
US
QNCX
+0.93%
© 2026 Longbridge｜Disclaimer